IN2015DN00833A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00833A IN2015DN00833A IN833DEN2015A IN2015DN00833A IN 2015DN00833 A IN2015DN00833 A IN 2015DN00833A IN 833DEN2015 A IN833DEN2015 A IN 833DEN2015A IN 2015DN00833 A IN2015DN00833 A IN 2015DN00833A
- Authority
- IN
- India
- Prior art keywords
- pemetrexed
- crystalline form
- salt
- synthesis
- lysine salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention refers to a process for the synthesis of pemetrexed and salts thereof in particular to a lysine salt thereof to said salt as such and to pharmaceutical compositions that comprise the same. Furthermore the present disclosure also relates to a crystalline form of the synthesis intermediate pemetrexed diethyl ether and a crystalline form of the pemetrexed lysine salt.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000398A ITRM20120398A1 (en) | 2012-08-08 | 2012-08-08 | PEMETREXED SYNTHESIS PROCESS AND ITS LYSINE SALT. |
| PCT/IB2013/056497 WO2014024164A1 (en) | 2012-08-08 | 2013-08-08 | Process for the preparation of pemetrexed and lysin salt thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00833A true IN2015DN00833A (en) | 2015-06-12 |
Family
ID=47018368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN833DEN2015 IN2015DN00833A (en) | 2012-08-08 | 2013-08-08 |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP2882753B1 (en) |
| KR (1) | KR102288417B1 (en) |
| CN (1) | CN104736540B (en) |
| AU (1) | AU2013301156B2 (en) |
| BR (1) | BR112015002429A8 (en) |
| CY (1) | CY1118514T1 (en) |
| DK (1) | DK2882753T3 (en) |
| ES (1) | ES2607890T3 (en) |
| HK (1) | HK1209426A1 (en) |
| HR (1) | HRP20170011T1 (en) |
| HU (1) | HUE032304T2 (en) |
| IN (1) | IN2015DN00833A (en) |
| IT (1) | ITRM20120398A1 (en) |
| LT (1) | LT2882753T (en) |
| MX (1) | MX362858B (en) |
| PL (1) | PL2882753T3 (en) |
| PT (1) | PT2882753T (en) |
| RS (1) | RS55515B1 (en) |
| RU (1) | RU2609006C2 (en) |
| SI (1) | SI2882753T1 (en) |
| SM (1) | SMT201600474B (en) |
| TW (1) | TWI609017B (en) |
| WO (1) | WO2014024164A1 (en) |
| ZA (1) | ZA201501549B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107641124A (en) * | 2016-07-22 | 2018-01-30 | 上海创诺制药有限公司 | A kind of pemetrexed diacid novel crystal forms and preparation method thereof |
| CN109836425B (en) * | 2017-11-24 | 2023-01-24 | 江苏创诺制药有限公司 | Preparation process of synthetic pemetrexed |
| CN110128428A (en) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | Pemetrexed alanine salt |
| CN110128427A (en) * | 2018-02-09 | 2019-08-16 | 鲁南制药集团股份有限公司 | Pemetrexed valine salt |
| CN110128426B (en) * | 2018-02-09 | 2021-12-14 | 鲁南制药集团股份有限公司 | Pemetrexed glutamate |
| CN111333658A (en) * | 2020-05-06 | 2020-06-26 | 贵州联科中贝制药科技有限公司 | Preparation method of pemetrexed disodium hydrate |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0440795B1 (en) | 1988-10-31 | 1994-10-19 | MITSUI TOATSU CHEMICALS, Inc. | Process for preparing organic group-substituted sodium aluminum hydride |
| IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | N-(disubstituted-1h-pyrrolo [2,3-d] pyrimidin-3-ylacyl)-glutamic acid derivatives their preparation and pharmaceutical compositions containing them |
| KR0162654B1 (en) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-[pyrrolo (2, 3-d) pyrimidin-3yl acryl]-glutamic acid derivatives |
| US5416211A (en) | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
| RU2127274C1 (en) * | 1992-09-25 | 1999-03-10 | Эли Лилли Энд Компани | METHOD OF SYNTHESIS OF 5-SUBSTITUTED PYRROLO[2,3-α]- -PYRIMIDINES |
| DE19725647A1 (en) | 1997-06-18 | 1998-12-24 | Basf Ag | Cyclopenta [I] phenanthrene metal complex catalyst systems |
| ZA987550B (en) | 1997-09-26 | 2000-02-21 | Lilly Co Eli | Processes and intermediates useful to make antifolates. |
| PT1259513E (en) | 2000-02-25 | 2004-02-27 | Lilly Co Eli | NEW CRYSTALLINE FORM OF N-4 - [(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO-2,3-D | PYRIMIDIN-5-YL) ETHYL ACID | - BENZOIL | -L-GLUTAMIC AND PROCESS FOR THEIR OBTENTION |
| WO2008021385A2 (en) | 2006-08-14 | 2008-02-21 | Sicor Inc. | Processes for preparing intermediates of pemetrexed |
| KR20090052355A (en) * | 2006-08-14 | 2009-05-25 | 시코르, 인크. | Highly pure pemetrexed diacid and processes for the preparation thereof |
| CN101591247B (en) * | 2008-05-30 | 2012-09-05 | 上海希迪制药有限公司 | Method for synthesizing 4-(4-carbomethoxyphenyl) butyraldehyde |
| IT1401677B1 (en) * | 2010-07-22 | 2013-08-02 | Chemi Spa | NEW PROCESS FOR THE SYNTHESIS OF PEMETREXED DISODIUM SALT |
| WO2012015810A2 (en) | 2010-07-28 | 2012-02-02 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
| WO2012056285A1 (en) * | 2010-10-25 | 2012-05-03 | Fresenius Kabi Oncology Ltd. | An improved process for the preparation of pemetrexed |
-
2012
- 2012-08-08 IT IT000398A patent/ITRM20120398A1/en unknown
-
2013
- 2013-08-06 TW TW102128058A patent/TWI609017B/en active
- 2013-08-08 RU RU2015108042A patent/RU2609006C2/en active
- 2013-08-08 KR KR1020157005932A patent/KR102288417B1/en active IP Right Grant
- 2013-08-08 PL PL13777144T patent/PL2882753T3/en unknown
- 2013-08-08 DK DK13777144.0T patent/DK2882753T3/en active
- 2013-08-08 PT PT137771440T patent/PT2882753T/en unknown
- 2013-08-08 LT LTEP13777144.0T patent/LT2882753T/en unknown
- 2013-08-08 ES ES13777144.0T patent/ES2607890T3/en active Active
- 2013-08-08 BR BR112015002429A patent/BR112015002429A8/en not_active Application Discontinuation
- 2013-08-08 MX MX2015001712A patent/MX362858B/en active IP Right Grant
- 2013-08-08 WO PCT/IB2013/056497 patent/WO2014024164A1/en active Application Filing
- 2013-08-08 SI SI201330427A patent/SI2882753T1/en unknown
- 2013-08-08 HU HUE13777144A patent/HUE032304T2/en unknown
- 2013-08-08 CN CN201380041935.8A patent/CN104736540B/en active Active
- 2013-08-08 IN IN833DEN2015 patent/IN2015DN00833A/en unknown
- 2013-08-08 AU AU2013301156A patent/AU2013301156B2/en active Active
- 2013-08-08 RS RS20161202A patent/RS55515B1/en unknown
- 2013-08-08 EP EP13777144.0A patent/EP2882753B1/en active Active
-
2015
- 2015-03-06 ZA ZA2015/01549A patent/ZA201501549B/en unknown
- 2015-10-19 HK HK15110234.8A patent/HK1209426A1/en unknown
-
2016
- 2016-12-28 SM SM201600474T patent/SMT201600474B/en unknown
- 2016-12-28 CY CY20161101351T patent/CY1118514T1/en unknown
-
2017
- 2017-01-05 HR HRP20170011TT patent/HRP20170011T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1118514T1 (en) | 2017-07-12 |
| SI2882753T1 (en) | 2017-02-28 |
| PL2882753T3 (en) | 2017-04-28 |
| ZA201501549B (en) | 2016-01-27 |
| HK1209426A1 (en) | 2016-04-01 |
| ES2607890T3 (en) | 2017-04-04 |
| DK2882753T3 (en) | 2017-01-16 |
| HUE032304T2 (en) | 2017-09-28 |
| ITRM20120398A1 (en) | 2014-02-09 |
| SMT201600474B (en) | 2017-03-08 |
| HRP20170011T1 (en) | 2017-03-10 |
| CN104736540B (en) | 2017-08-25 |
| RS55515B1 (en) | 2017-05-31 |
| RU2015108042A (en) | 2016-09-27 |
| MX2015001712A (en) | 2015-08-14 |
| TW201412741A (en) | 2014-04-01 |
| KR102288417B1 (en) | 2021-08-11 |
| AU2013301156A1 (en) | 2015-02-05 |
| BR112015002429A8 (en) | 2019-07-30 |
| AU2013301156B2 (en) | 2017-08-31 |
| BR112015002429A2 (en) | 2017-07-04 |
| EP2882753B1 (en) | 2016-10-05 |
| KR20150045458A (en) | 2015-04-28 |
| RU2609006C2 (en) | 2017-01-30 |
| LT2882753T (en) | 2016-12-12 |
| MX362858B (en) | 2019-02-20 |
| EP2882753A1 (en) | 2015-06-17 |
| WO2014024164A1 (en) | 2014-02-13 |
| CN104736540A (en) | 2015-06-24 |
| TWI609017B (en) | 2017-12-21 |
| PT2882753T (en) | 2016-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015KN00262A (en) | ||
| PL3409674T3 (en) | Process for preparing compositions useful for treating disorders related to kit | |
| MD20150091A2 (en) | Anti-viral compounds | |
| IN2014MN02598A (en) | ||
| ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
| IN2015DN00833A (en) | ||
| EA029539B8 (en) | Pharmaceutical composition of sitagliptin | |
| MX349224B (en) | Pharmaceutical composition for use in the treatment of a neurodegenerative disease. | |
| MX2014004196A (en) | Rasagiline citramide. | |
| MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
| MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
| NZ708371A (en) | Methods for treating pruritus | |
| MX337721B (en) | Heteroaryl compounds as 5-ht4 receptor ligands. | |
| MY160902A (en) | Process for the preparation of the L-arginine salt of perindopril | |
| IN2014DN06964A (en) | ||
| MX2014002625A (en) | Novel compositions for producing cast polyamides. | |
| MX339858B (en) | Novel compounds as histamine h3 receptor ligands. | |
| IN2014MN01671A (en) | ||
| IN2013MU03070A (en) | ||
| IN2015DN00085A (en) | ||
| IN2015DN00950A (en) | ||
| IN2014DN03245A (en) | ||
| IN2014DN09451A (en) | ||
| HK1211845A1 (en) | Processes for preparing toothpaste compositions | |
| MX351789B (en) | New composition for producing cast polyamides. |